Connecticut Innovations announced this week that it has selected Orthozon Technologies L.L.C., a Stamford-based medical device company, to receive funding in its latest round of pre-seed funding for startups focused on innovations in bioscience and medical devices.
CI is the state’s quasi-public financing entity, focused on providing financial assistance to companies starting and growing in Connecticut. This round of funding, Orthozon, along with three other bioscience companies, will receive a total of $560,000.
Slated to receive $150,000, Orthozon develops spinal implants and medical instrumentation for minimally-invasive surgeries. Company officials also plan to adapt their technology for additional markets, including cardiology, gastroenterology, neurosurgery, otolaryngology and other orthopedic areas.
“The fields of biotechnology and medical science continue to expand in Connecticut, and to grow in their importance to our state’s economy,” said State Sen. Carlo Leone of Stamford in a press release. “I welcome the development of Orthozon Technologies in Stamford, and I applaud Connecticut Innovations for providing this early-stage support.”
The three other companies to receive funding are in Farmington.
